NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

MiniMed Group, Inc. (MMED) Stock Analysis

MiniMed Group, Inc. (MMED) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

MMED

$17.80

+$0.31 (+1.77%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MMED with… →

MMED Key Statistics

As of Oct 21, 2026
Trading
Open
$17.31
Previous Close
$17.49
Day's Range
17.29–18.11
52-Week Range
10.65–24.43
Volume
10.29M
Valuation
Market Cap
$5.01B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
25.64
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.55
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.53
Financials (FY)
Revenue (FY)
$3.10B+14.25%
Net Income (FY)
−$333.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
−9.74%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
281.35M
Dividend and dates
Earnings Date
November 16, 2026estimated
Avg Volume
6.36M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

MiniMed Group, Inc. (MMED) has a market capitalization of $5.01B.

In fiscal 2025, MMED reported revenue of $3.10B.

MMED Revenue and Earnings by Fiscal Year

FY ends April
Fiscal yearRevenueNet incomeNet margin
2025$3.10B−$333.00M−10.7%
2024$2.72B−$213.00M−7.8%
2023$2.47B−$112.00M−4.5%
2022$2.25B−$96.00M−4.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.10B$1.68B−$159.00M−$333.00M−10.7%
2024$2.72B$1.53B$33.00M−$213.00M−7.8%
2023$2.47B$1.44B−$61.00M−$112.00M−4.5%
2022$2.25B$1.31B−$69.00M−$96.00M−4.3%

Annual figures as reported, in the company's reporting currency. As of April 30, 2026.

MMED Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricMMEDMedical Instruments & Supplies medianvs median
P/S ratio1.552.6040% below
Profit margin−9.74%1.62%11.4 pts below

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values MiniMed Group, Inc. (MMED) at $5.01B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 8,000 employees.

Over the past 52 weeks the price has ranged from $10.65 to $24.43. The most recent close on file for MMED is $17.80, dated October 21, 2026. That is +$0.31 (+1.77%) against the previous close. The latest close sits 67.14% above that 52-week low.

Financial Health

In fiscal 2025, MiniMed Group, Inc. reported revenue of $3.10B. That is +14.25% against the prior fiscal year, when revenue was $2.72B. The same year closed with a net loss of $333.00M. The reported profit margin is −9.74%. That is 11.4 percentage points below the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to −1.53.

Across the 4 fiscal years on file, revenue moves from $2.25B in 2022 to $3.10B in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 25.64. The price-to-sales ratio is 1.55. On price-to-sales that is 40.17% below the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The stored price history starts on March 6, 2026, and the total return since then is −3.73%.

Growth & Income

The record shows no dividend for MMED.

So far in 2026 the total return is −3.73%.

Peer Comparison

MiniMed Group, Inc. (MMED) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
MiniMed Group, Inc. MMED $5.01B —
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. MiniMed Group, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About MiniMed Group, Inc.

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

Visit website →